# COPAN Diagnostics

> COPAN Diagnostics is the California-based manufacturing and distribution arm of Italy’s privately held Copan Group, serving the Americas with specimen collection and transport devices, laboratory automation, and digital microbiology software. Its portfolio connects FLOQSwabs, ESwab and UTM to WASP specimen processing, WASPLab incubation and imaging, and PhenoMATRIX image assessment.

- **Founded:** 1994
- **Headquarters:** Murrieta, United States
- **Founders:** Daniele Triva (Co-founder; inventor of FLOQSwabs), Norman Sharples (Co-founder; former CEO)
- **Products:** FLOQSwabs, ESwab, UTM Universal Transport Medium, WASP, WASPLab
- **Notable:** Patented flocked-swab technology originated in 2003., Apple reported more than 15 million COVID-19 collection kits shipped by February 2021 following manufacturing support., PhenoMATRIX received FDA 510(k) clearance K251511 on January 22, 2026.

## Products & services

- **FLOQSwabs** — Patented nylon flocked collection swabs in anatomical tip configurations.
- **ESwab** — Flocked swab with 1 mL Liquid Amies medium for bacterial collection and transport and multiple aliquots.
- **UTM Universal Transport Medium** — Transport and stabilization of upper respiratory specimens for compatible molecular viral assays; current intended use updated under K232357.
- **WASP** — Walk-Away Specimen Processor for automated specimen inoculation and streaking.
- **WASPLab** — Modular culture-plate incubation, imaging, digital reading and workflow management.
- **PhenoMATRIX** — AI-assisted culture-image assessment and sorting using laboratory-defined rules and LIS context; FDA clearance K251511 dated January 22, 2026.
- **Colibrí** — Automated colony picking and preparation for identification and antimicrobial susceptibility testing.
- **Radian** — Automated disk-diffusion susceptibility-test setup and interpretation; availability varies by market.
- **UriVerse** — Automated urine specimen de-capping, barcode labeling, aliquoting and re-capping.
- **4N6FLOQSwabs** — Specialized sample collection for forensic and genetic applications.

## Achievements

- Patented flocked-swab technology originated in 2003.
- Apple reported more than 15 million COVID-19 collection kits shipped by February 2021 following manufacturing support.
- PhenoMATRIX received FDA 510(k) clearance K251511 on January 22, 2026.

## Latest updates

- **2026-02** — Announced PhenoMATRIX FDA 510(k) clearance, issued January 22, 2026.
- **2025-09** — Announced more than $7 million in U.S. manufacturing investments in California and Puerto Rico; operations were projected for Q1 2026.
- **2025-08** — Appointed Dr. Hema Kapoor Director of Medical and Scientific Affairs for the Americas.
- **2025-08** — Launched UriVerse for automated urine specimen aliquoting in the U.S.
- **2025-02** — Reported Hospital Angeles Pedregal’s WASPLab installation in Mexico as the first in Latin America.

## Links

- Website: https://www.copanusa.com/
- LinkedIn: https://www.linkedin.com/company/copan-diagnostics-inc-/
- Twitter/X: https://twitter.com/CopanUSA
- YouTube: https://www.youtube.com/COPANusa
- Instagram: https://www.instagram.com/copan_usa/
- Facebook: https://www.facebook.com/CopanUSA

---

Profile page: https://yespress.io/copan-diagnostics
Published by YesPress — https://yespress.io
Last updated: 2026-10-02